MedChemComm · 2015 · 67 citations · 36 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoverySynthetic Medicinal ChemistryCytotoxic ChemotherapyHeterocyclic ChemistryOncology PharmacologyMedicinal Heterocycles
value of 1.7 µM. The potent cytotoxicity of these novel compounds and their inhibition of tubulin dynamics make these triazole analogues promising candidates for development as anti-cancer drugs.
36
Christian W. Tornøe, Caspar Christensen, Morten Meldal · The Journal of Organic Chemistry · 2002 · 8.5K citations
Ruthenium-Catalyzed Cycloaddition of Alkynes and Organic Azides
Li Zhang, Xinguo Chen, Peng Xue et al. · Journal of the American Chemical Society · 2005 · 1.1K citations
Larry Rubinstein, Robert H. Shoemaker, Kenneth D. Paull et al. · JNCI Journal of the National Cancer Institute · 1990 · 931 citations
Medicine, Oncology, Pharmacology +14
Le Wang, Keith W. Woods, Qun Li et al. · Journal of Medicinal Chemistry · 2002 · 421 citations · Full text